5-amino-1mq coa 50MG 5-Amino-1MQ Peptide | Puratek Peptides

Users commonly report 2.5-5mg per day via subcutaneous injection, often once daily or split

A quinolinium-based, selective NNMT inhibitor used to interrogate NNMT biology in cells and animal models of obesity, insulin resistance, and related metabolic phenotypes (commonly as the iodide salt

Roles of Nicotinamide N-Methyltransferase in Obesity and Type 2 Diabetes (review)

In-Vitro Pharmacology and Selectivity Biochemical profiling places 5-Amino-1MQ potency for research NNMT in the low-micromolar IC range under standardized assay conditions, with cell-based EC values in the low micromolar range for lowering 1-MNA and suppressing lipogenesis

Licensed Peptides supplies 5-Amino-1MQ strictly for laboratory research purposes